secwatch.observer — SEC 8-K summary
======================================

Issuer:     bioAffinity Technologies, Inc. (BIAF)
CIK:        0001712762
Form:       8-K
Filed at:   2025-10-20T23:59:59+00:00
Accession:  0001493152-25-018643
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

bioAffinity Technologies to present CyPath® Lung processing research at CHEST 2025
--------------------------------------------------------------------------------

- Poster presented Oct 22, 2025 by Rossella Titone, PhD at poster board #4324.
- Study evaluates sputum storage and shipping temperature effects on flow cytometry outcomes.
- Research supports protocols for home-collected sputum samples with two-day result turnaround.
- CyPath® Lung previously reported 92% sensitivity, 87% specificity, 88% accuracy in early-stage lung cancer detection.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1712762/000149315225018643/0001493152-25-018643-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1712762/000149315225018643/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-018643

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer